Yhdistynyt kuningaskunta - englanti - VMD (Veterinary Medicines Directorate)

piramal critical care limited - isoflurane - inhalation vapour, solution - neurological agent general anaesthetic - cats, dogs, horses, mouse, ornamental birds, rabbits, rat, reptiles

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

piramal critical care limited - isoflurane - inhalation vapour, liquid - 1000 milligram(s)/gram - isoflurane - cats, dogs, ferrets, gerbils, guinea pigs, hamsters, horses, other birds, reptiles - neurological preparations

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

piramal critical care b.v. - isoflurane - inhalation vapour, liquid - 1000 milligram(s)/gram - isoflurane

Yhdistynyt kuningaskunta - englanti - VMD (Veterinary Medicines Directorate)

piramal critical care limited - isoflurane - inhalation vapour, liquid - neurological agent general anaesthetic - cats, chinchilla, dogs, ferrets, gerbil, guinea pig, hamster, horses, mouse, ornamental birds, rat, reptiles

Yhdysvallat - englanti - NLM (National Library of Medicine)

piramal critical care inc - sevoflurane (unii: 38lvp0k73a) (sevoflurane - unii:38lvp0k73a) - sevoflurane 1 ml in 1 ml - sojourn ® (sevoflurane, usp) is indicated for induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery. sojourn ® (sevoflurane, usp) should be administered only by persons trained in the administration of general anesthesia. facilities for maintenance of a patent airway, artificial ventilation, oxygen enrichment, and circulatory resuscitation must be immediately available. since level of anesthesia may be altered rapidly, only vaporizers producing predictable concentrations of sevoflurane, usp should be used. • known or suspected genetic susceptibility to malignant hyperthermia. (see warnings - malignant hyperthermia,clinical pharmacology - pharmacogenomics ). • known or suspected sensitivity to sevoflurane or to other halogenated inhalational anesthetics.

Yhdysvallat - englanti - NLM (National Library of Medicine)

piramal critical care inc - sevoflurane (unii: 38lvp0k73a) (sevoflurane - unii:38lvp0k73a) - sevoflurane 1 ml in 1 ml - sevoflurane, usp is indicated for induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery. sevoflurane, usp should be administered only by persons trained in the administration of general anesthesia. facilities for maintenance of a patent airway, artificial ventilation, oxygen enrichment, and circulatory resuscitation must be immediately available. since level of anesthesia may be altered rapidly, only vaporizers producing predictable concentrations of sevoflurane, usp should be used. • known or suspected genetic susceptibility to malignant hyperthermia. (see warnings - malignant hyperthermia, clinical pharmacology - pharmacogenomics ). • known or suspected sensitivity to sevoflurane or to other halogenated inhalational anesthetics.

Belgia - englanti - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

piramal critical care b.v. - desflurane 100 % - inhalation vapour, liquid - 100 % - desflurane - desflurane

Yhdysvallat - englanti - NLM (National Library of Medicine)

piramal critical care inc - sevoflurane (unii: 38lvp0k73a) (sevoflurane - unii:38lvp0k73a) - sevoflurane, usp is indicated for induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery. sevoflurane, usp should be administered only by persons trained in the administration of general anesthesia. facilities for maintenance of a patent airway, artificial ventilation, oxygen enrichment, and circulatory resuscitation must be immediately available. since level of anesthesia may be altered rapidly, only vaporizers producing predictable concentrations of sevoflurane should be used. • known or suspected genetic susceptibility to malignant hyperthermia. (see warnings-malignant hyperthermia,clinical pharmacology - pharmacogenomics). • known or suspected sensitivity to sevoflurane or to other halogenated inhalational anesthetics.

Saudi-Arabia - englanti - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

piramal critical care b.v, netherlands - fentanyl - solution - 50 µ/ml

Saudi-Arabia - englanti - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

piramal critical care b.v, netherlands - fentanyl - solution - 50 mg/ml